Navigation Links
Severe Bacterial Strain Found in Cystic Fibrosis Patients in Canada

TUESDAY, Nov. 16 (HealthDay News) -- Researchers have found that many cystic fibrosis (CF) patients in Canada have a common transmissible strain of the bacteria Pseudomonas aeruginosa, which can increase the risk of death or the need for a lung transplant.

It's not known if the strain, first identified in the U.K., is yet common among CF patients in the United States.

Researchers looked at 446 CF patients in Ontario and found that 102 of them were infected with one of two common strains. Sixty-seven were infected with strain A, 32 were infected with strain B, and three were infected with both strains.

The study appears in the Nov. 17 issue of the Journal of the American Medical Association.

According to background information in the study, the significant variation in the prognosis of patients with P aeruginosa may partly result from differences among infecting strains.

Strain A was genetically identical to the Liverpool (England) epidemic strain first identified in 1996, but strain B has not previously been regarded as an epidemic strain. The three-year risk of death or need for a lung transplant was twice as high in patients with strain A (18.6 percent) than in those with unique strains (8.7 percent). The risk for patients with strain B was similar to those with unique strains.

"The results of our study indicate that a sizable minority of adult Canadian patients with CF living in the province of Ontario are infected with 1 of 2 common strains of P aeruginosa. The most prevalent transmissible strain found was the Liverpool epidemic strain, which was found to infect more than 15 percent of Ontario patients. This same strain is known to infect approximately 11 percent of patients with CF who receive their care in 1 of 15 CF clinics in England and Wales," wrote Dr. Shawn D. Aaron of Ottawa Hospital Research Institute and colleagues in a news release from the journal publisher.

"Our study is the first report to suggest that common strains of P aeruginosa are shared among patients located on different continents," they added. "Our data suggest that cross-infection with P aeruginosa has occurred widely both within Ontario and between CF centers in the United Kingdom and Canada."

More information

The U.S. National Heart, Lung, and Blood Institute has more about cystic fibrosis.

-- Robert Preidt

SOURCE: Journal of the American Medical Association, news release, Nov. 16, 2010

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Rare, Severe Form of Morning Sickness Appears to Be Genetic
2. Severe Acne May Up Suicide Risk: Study
3. A comparison of severe outcomes during the waves of pandemic (H1N1) 2009
4. Major clinical trial prompts call for change to treatment guidelines for severe malaria worldwide
5. Discovery shows promise against severe side effects
6. Severely injured should go directly to trauma center: Research
7. Johns Hopkins researchers turn off severe food allergies in mice
8. New treatment for severe aortic stenosis shown to save lives, Stanford researchers say
9. Disc Battery Ingestion May Cause Severe Injuries in Babies
10. Gene Rx May Fight Severe Blood Disorder
11. College Campuses See Rise in Cases of Severe Mental Illness
Post Your Comments:
Related Image:
Severe Bacterial Strain Found in Cystic Fibrosis Patients in Canada
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, Vitalalert ... Organizations, One Beat ” campaign. The partnership between the two groups began in 2014 ... MAP International’s cause. , MAP International was founded in 1954 and is an international ...
(Date:11/25/2015)... ... ... On November 25, 2015, officials of Narconon Arrowhead , the drug rehabilitation ... new cutting edge recovery program that has been 50 years in the making. ... with the purpose to free addicts from the symptoms and negative behaviors of addiction. ...
(Date:11/25/2015)... ... ... Smiles by Stevens is pleased to announce the addition of Botox® for ... aware of the benefits of Botox® in the treatment of moderate facial wrinkling, few ... and pain as a result of Jaw Tension, TMJ (temporo-mandibular joint) disorder, and Bruxism ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical Study conducted by an ... IL, UV Angel is evaluating the efficacy of its product and its disinfection protocol. ... 30 beds) from May 2014 through October 2015 at a 360-bed, acute-care, academic medical ...
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015 Kitov Pharma ceuticals ... a biopharmaceutical company focused on the development of therapeutic ... today announced the closing of its previously announced underwritten ... ), each representing 20 ordinary shares of the Company, ... ADSs and warrants were issued in a fixed combination ...
(Date:11/25/2015)...  Today AVACEN Medical announced the issue of United States patent No. ... ". This patent shields the company,s AVACEN 100 dry heat therapy medical device and specific methods ... Photo - ... ... ...
(Date:11/25/2015)... , Nov. 25, 2015 USP 800 ... drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, ... technicians). The chapter also covers all entities which ... pharmacies, hospitals, other healthcare institutions, patient treatment clinics, ... --> --> What is ...
Breaking Medicine Technology: